| Literature DB >> 33623723 |
Giulio Edoardo Vigni1, Francesco Bosco1, Alessio Cioffi1, Lawrence Camarda1.
Abstract
In patients over 65y.o. who were surgically treated for a hip fracture, electrolytes have not been specifically studied as predictors of mortality. The main purpose of this study was to assess whether electrolytes and chronic kidney disease (CKD) stages, evaluated at admission, could represent a pre-operative prognostic factor in this population. Moreover, the role of epidemiological and clinical parameters was analyzed with and without a surgical timing stratification. This retrospective study included 746 patients. For each patient, their age, gender, fracture classification, Hb value, comorbidities, ASA class, chronic kidney disease, creatinine levels, electrolytes and surgical timing were collected. CKD-epi, MDRD, modified MDRD and BIS1 were used to obtain eGFR and CKD stages. All parameters were analyzed individually and in relation to the different surgical timing. Descriptive statistics, Chi-square test and survivability analysis with Kaplan Meier curve were used. In patients with a hip fracture non-significant association with increased mortality was shown for the following variables: Hb value, sodium values, calcium values, CKD stages and creatinine values. Otherwise altered kalemia was associated with a statistically significant increase in mortality as well as male gender, two or more comorbid medical conditions, advanced age (>75 years), higher ASA class. Surgery performed within 72h resulted in a statistically significant reduction in mortality at 6 months and, when performed in 24h-48h, a further reduction at 4 years. Age and ASA class statistically significant increased mortality regardless the surgical timing. Male patients operated after 48h from hospitalization were associated with a statistically significant increase in mortality rate. Two or more comorbidities were related to a statistically significant increased number of deaths when patients were treated after 96h. Altered kalemia values at hospitalization are associated with a statistically significant increase in mortality in patients operated after 72h from admission.Entities:
Keywords: basic research; electrolytes; fragility fractures; geriatric medicine; geriatric trauma; hip fracture; kidney; mortality; mortality risk; trauma surgery
Year: 2021 PMID: 33623723 PMCID: PMC7876745 DOI: 10.1177/2151459321991503
Source DB: PubMed Journal: Geriatr Orthop Surg Rehabil ISSN: 2151-4585
Patient Population.
| Total n° patient population | 746 | ||
|---|---|---|---|
| Total n° deaths | 251 | ||
| Gender | M: 189 (25.3%) | F: 557 (74.7%) | |
| Age | Min: 65 | Average: 82 | Max: 100 |
| Operated patients | Yes: 660 (88.5%) | No: 86 (11.5%) | |
| Type of Fracture | Extra-capsular: 511 (68.5%) | Intra-capsular: 235 (31.5%) | |
Patient Population: Kidney Function.
| N° patients | Average | Min | Max | |
|---|---|---|---|---|
| Kidney function | ||||
| Creatinine | 694 | 1.13 | 0.38 | 8.99 |
| eGFR (Treated) | 648 | 60.85 | 4.79 | 106.27 |
Increase in Mortality: CKD Stages Based on CKD-EPI Equation in Operated Patients.
| CKD Stages | Total n° patients | N° treated patients | Deaths | Deaths % | Increase in mortality correlated to Stage 1 |
|---|---|---|---|---|---|
| Stage 1 | 65 | 60 | 15 | 25,0 | |
| Stage 2 | 293 | 273 | 83 | 30,4 | OR: 1.3105 (CI:0.69-2.48) p value >0.05 |
| Stage 3 | 258 | 246 | 81 | 32,9 | OR: 1.4727 (CI:0.78-2.79) p value >0.05 |
| Stage 4 | 61 | 54 | 20 | 37,0 | OR: 1.7647 (CI:0.79-3.94) p value >0.05 |
| Stage 5 | 17 | 15 | 7 | 46,7 | OR: 2.6250 (CI:0.81-8.46) p value >0.05 |
| Total | 694 | 648 | 206 | ||
| CKD Stages | Increase in mortality correlated to moderate stages | ||||
| Moderate (Stages 1, 2, 3) | 579 | 179 | 30,9 | ||
| Severe (Stages 4, 5) | 69 | 27 | 39,1 | OR: 1.4366 (CI:0.86-2.40) p value >0.05 |
Increase in Mortality: CKD Stages Based on MDRD Equation in Operated Patients.
| CKD Stages | N° patients | Deaths | Deaths % | Increase in mortality correlated to Stage 1 |
|---|---|---|---|---|
| Stage 1 | 153 | 45 | 29,4 | |
| Stage 2 | 219 | 62 | 28,3 | OR: 0.9478 (CI:0.60-1.49) p value >0.05 |
| Stage 3 | 220 | 78 | 35,5 | OR: 1.3183 (CI:0.85-2.06) p value >0.05 |
| Stage 4 | 45 | 17 | 37,8 | OR: 1.4571 (CI:0.73-2.92) p value >0.05 |
| Stage 5 | 11 | 4 | 36,4 | OR: 1.3714 (CI:0.38-4.92) p value >0.05 |
| Total | 648 | 206 | ||
| CKD Stages | N° patients | Deaths | Deaths % | Increase in mortality correlated to moderate stages |
| Moderate (Stages 1, 2, 3) | 592 | 185 | 31,3 | |
| Severe (Stages 4, 5) | 56 | 21 | 37,5 | OR: 1.32 (CI:0.75-2.33) p value >0.05 |
Increase in Mortality: CKD Stages Based on MDRD Modified Equation in Operated Patients.
| CKD Stages | N° patients | Deaths | Deaths % | Increase in mortality correlated to Stage 1 |
|---|---|---|---|---|
| Stage 1 | 128 | 38 | 29,7 | |
| Stage 2 | 207 | 60 | 29,0 | OR: 0.9667 (CI:0.60-1.57) p value >0.05 |
| Stage 3 | 249 | 84 | 33,7 | OR: 1.2057 (CI:0.76-1.91) p value >0.05 |
| Stage 4 | 50 | 17 | 34,0 | OR: 1.2201 (CI:0.61-2.45) p value >0.05 |
| Stage 5 | 14 | 7 | 50,0 | OR: 2.3684 (CI:0.78-7.22) p value >0.05 |
| Total | 648 | 206 | ||
| CKD Stages | N° patients | Deaths | Deaths % | Increase in mortality correlated to moderate stages |
| Moderate (Stages 1, 2, 3) | 584 | 182 | 31,2 | |
| Severe (Stages 4, 5) | 64 | 24 | 37,5 | 1.3253 (CI:0.76-2.26) p value >0.05 |
Increase in Mortality: CKD Stages Based on BIS1 Equation in Operated Patients.
| CKD Stages | N° patients | Deaths | Deaths % | Increase in mortality correlated to Stage 1 |
|---|---|---|---|---|
| Stage 1 | 28 | 7 | 25,0 | |
| Stage 2 | 209 | 60 | 28,7 | OR: 1.2081 (CI:0.49-2.99) p value >0.05 |
| Stage 3 | 343 | 112 | 32,7 | OR: 1.4545 (CI:0.60-3.52) p value >0.05 |
| Stage 4 | 57 | 23 | 40,4 | OR: 2.0294 (CI:0.74-5.55) p value >0.05 |
| Stage 5 | 11 | 4 | 36,4 | OR: 1.7143 (CI:0.39-7.66) p value >0.05 |
| Total | 648 | 206 | ||
| CKD Stages | N° patients | Deaths | Deaths % | Increase in mortality correlated to moderate stages |
| Moderate (Stages 1, 2, 3) | 580 | 182 | 31,4 | |
| Severe (Stages 4, 5) | 68 | 27 | 39,7 | OR: 1.4753 (CI:0.88-2.47) p value >0.05 |
Patient Population: Electrolytes Levels.
| Electrolytes | N° patients | Average | Min | Max |
|---|---|---|---|---|
| Na+ | 700 | 138.98 | 110 | 163 |
| K+ | 700 | 4.40 | 2.70 | 7.74 |
| Ca2+ | 682 | 8.40 | 4.60 | 11.43 |
Patient Population: Electrolytes Levels in Operated Patients.
| Electrolytes | Total n° of patients | |||
|---|---|---|---|---|
| Na+ | Hypo | Normal values | Hyper | |
| N° of patients | 653 | 68 | 563 | 22 |
| K+ | Hypo | Normal values | Hyper | |
| N° of patients | 653 | 36 | 553 | 64 |
| Ca2+ | Hypo | Normal values | Hyper | |
| N° of patients | 640 | 369 | 269 | 2 |
Increase in Mortality: Altered Levels of Electrolytes in Operated Patients.
| Electrolytes | Altered levels < n.v. | Altered levels > n.v. |
|---|---|---|
| Na+ | OR: 1.02 (CI:0.61-1.71) p value >0.05 | OR: 1.43 (CI:0.66-3.12) p value >0.05 |
| K+ | OR: 2.01 (CI:1.03-3.91) p value <0.05 | OR: 2.48 (CI:1.44-4.29) p value <0.05 |
| Ca2+ | OR: 1.35 (CI:0.96-1.90) p value >0.05 | OR: 2.54 (CI:0.16-41.12) p value >0.05 |
Increase in Mortality: Altered Kalemia Levels Correlated to Surgical Timing.
| IperK+ | Surgical timing | Increase in mortality |
|---|---|---|
| < 48H | OR: 1.75 p value >0.05 | |
| > 48H | OR: 2.60 p value <0.05 | |
| < 72H | OR: 1.49 p value >0.05 | |
| < 96H | OR: 2.09 p value <0.05 | |
| IperK | Surgical timing | Increase in mortality |
| > 48H | OR: 2.01 p value >0.05 | |
| < 72H | OR: 1.22 p value >0.05 |
Mortality Correlation in Patients Treated Within 72 and 48 Hours.
| Time from hospitalization (months) | Surgical timing | Surgical timing |
|---|---|---|
| 1 | OR: 0.81 (CI:0.39-1.70) p value >0.05 | OR: 1.57 (CI:0.72-3.43) p value >0.05 |
| 6 | OR: 0.65 (CI:0.44-0.98) p value <0.05 | OR: 0.78 (CI:0.48-1.27) p value >0.05 |
| 12 | OR: 0.61 (CI:0.42-0.89) p value <0.05 | OR: 0.80 (CI:0.52-1.24) p value >0.05 |
| 24 | OR: 0.59 (CI:0.42-0.82) p value <0.05 | OR: 0.69 (CI:0.46-1.04) p value >0.05 |
| 36 | OR: 0.58 (CI:0.42-0.81) p value <0.05 | OR: 0.68 (CI:0.45-1.10) p value >0.05 |
| 48 | OR: 0.58 (CI:0.42-0.81) p value <0.05 | OR: 0.67 (CI:0.45-0.99) p value <0.05 |